John Lacy Iii is Director of PROVECTUS BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 200,000 shares of PVCT, which is worth approximately $20,000. The most recent transaction as insider was on Nov 10, 2020, when has been sold 100,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200K
0% 3M change
0% 12M change
Total Value Held $20,000

John Lacy III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2020
BUY
Grant, award, or other acquisition
-
100,000 Added 33.33%
200,000 Common Stock
JLI

John Lacy Iii

Director
Knoxville, TN

Track Institutional and Insider Activities on PVCT

Follow PROVECTUS BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PVCT shares.

Notify only if

Insider Trading

Get notified when an Provectus Biopharmaceuticals, Inc. insider buys or sells PVCT shares.

Notify only if

News

Receive news related to PROVECTUS BIOPHARMACEUTICALS, INC.

Track Activities on PVCT